Back to LLY Stock Lookup

LLY – FDA

Apr 8, 2014 09:18 AM Eli Lilly & Co. (LLY) Believes 'Evidence Did Not Support the Claims' in Actos Suit
Apr 8, 2014 06:22 AM Eli Lilly (LLY), Takeda Fines Near-Record $9B in Diabetes Drug Case
Apr 1, 2014 09:11 AM Prasco, Lilly (LLY) Enter Agreement for AG Version of EVISTA
Apr 1, 2014 07:07 AM Lilly (LLY) Reports Alimta Vitamin Dosage Patent Upheld
Mar 21, 2014 08:27 AM Lilly (LLY), Boehringer Receive Positive Opinion from CHMP for Empagliflozin
Mar 4, 2014 09:36 AM Teva (TEVA) Announces Approval of Generic Evista Tablets 60 mg (LLY)
Feb 19, 2014 10:09 AM Eli Lilly (LLY) Ramucirumab Data a Positive for Dyax (DYAX), Needham & Company Says
Feb 19, 2014 08:01 AM Lilly (LLY) Reports REVEL Trial Met Overall Survival Primary Endpoint
Jan 31, 2014 11:31 AM Lilly (LLY) Doesn't Believe It Infringes on Any Sanofi (SNY) Patents
Jan 30, 2014 05:13 PM Sanofi (SNY) Slaps Lilly (LLY) with Lawsuit; Alleges Patent Infringement
Jan 30, 2014 06:30 AM Eli Lilly & Co. (LLY) Tops Q4 EPS by 1c; Raffirms Outlook
Jan 16, 2014 04:28 PM FDA Panel Doesn't Approve of Wider Use for J&J (JNJ), Bayer's Xarelto
Dec 20, 2013 02:06 PM Lilly (LLY), Boehringer NDA for Long-Acting Insulin Accepted by FDA
Dec 13, 2013 07:44 AM ImmunoGen (IMGN), Lilly (LLY) Enter Multi-Target Agreement Amendment
Dec 5, 2013 08:03 AM Lilly (LLY) Reports Edivoxetine Missed Primary Endpoints in Phase III
Nov 18, 2013 08:09 AM QIAGEN (QGEN), Lilly (LLY) Enter Third Companion Diagnostics Development Agreement
Oct 25, 2013 08:01 AM Lilly (LLY) Reports Approval of Expanded Indication for CIALIS
Oct 23, 2013 06:33 AM Lilly (LLY) Receives FDA Priority Review for Ramucirumab
Oct 3, 2013 07:02 AM Eli Lilly (LLY) Issus Near-, Mid-Term Outlook; Will Supplement Dividends with Buybacks
Sep 26, 2013 07:35 AM Lilly (LLY) Updates on Two Ramucirumab Phase IIIs; One Trial Met Primary Endpoint
Sep 6, 2013 12:22 PM FDA Approves Celgene's (CELG) ABRAXANE for Late-Stage Pancreatic Cancer (LLY)
Aug 13, 2013 09:13 AM Lilly's (LLY) Newest Lung Cancer Drug May Have $1.5B/yr Potential
Aug 13, 2013 08:06 AM Lilly (LLY) Reports SQUIRE Met Primary Endpoint in Stage IV NSCLC
Jul 24, 2013 06:47 AM Eli Lilly & Co. (LLY) Tops Q2 EPS by 15c; Boosts FY13 EPS Outlook
Jun 20, 2013 11:15 AM Boehringer, Lilly (LLY) Receive FDA Approval for Updates to TRADJENTA, JENTADUETO Tabs
Jun 18, 2013 10:08 AM FDA Investigating Two Deaths Following Injection of Lilly's (LLY) Antipsychotic Zyprexa Relprevv
Jun 13, 2013 04:41 PM Lilly and Co. (LLY) Ceases BACE Phase II Voluntarily; Sees Immaterial Charge
Jun 3, 2013 08:03 AM Lilly (LLY) Says PRONOUNCE Missed Primary Superiority Endpoint
May 10, 2013 08:02 AM Lilly (LLY) to Halt Enzastaurin Production Following Phase III; Sees Charge
Apr 16, 2013 08:08 AM Lilly (LLY) Reports Dulaglutide Met Primary Endpoints in Additional Phase IIs
Mar 26, 2013 11:26 AM Boehringer, Lilly (LLY) Empagliflozin MAA Accepted by EMA
Mar 19, 2013 08:04 AM Boehringer, Lilly (LLY) Launch MARLINA Trial
Mar 14, 2013 05:43 PM FDA to Review Certain Diabetes Drugs Over New Pancreas Concern (BMY) (LLY) (MRK)
Mar 7, 2013 06:43 AM Kowa, Lilly (LLY) Report LIVALO Met Primary Endpoint in Reducing LDL-C
Feb 13, 2013 04:18 PM Qiagen NV (QGEN) Enters Deal with Eli Lilly (LLY)
Feb 7, 2013 08:06 AM Eli Lilly (LLY) to Cease Tabalumab Phase 3 RA Program
Jan 15, 2013 03:39 PM Eli Lilly (LLY) Receives EC Approval of Amyvid for PET Imaging
Jan 7, 2013 11:14 AM Agilent's (A) Dako Enters Diagnostic Test Development Partnership with Lilly (LLY)
Jan 7, 2013 08:14 AM Boehringer, Lilly (LLY) Complete Four Phase 3s for Empagliflozin; Safety Profile Akin to Phase 2
Jan 7, 2013 08:13 AM Eli Lilly (LLY) Resumes Sole LY2605541 Development
Dec 20, 2012 12:45 PM Lilly (LLY) Reaches Agreement with SEC Over FCPA; Will Pay $29.4M in Settlement
Dec 13, 2012 08:04 AM Eli Lilly (LLY) to Discontinue One Tabalumab Phase 3 Study; Sees Q4 Charge
Dec 12, 2012 06:57 AM Lilly (LLY) Does Not Plan to Submit BLA for Solanezumab to FDA Following EXPEDITION Analysis
Dec 4, 2012 04:08 PM Anacor (ANAC) Achieves 2nd Candidate in Lilly (LLY) Collaboration
Nov 28, 2012 09:13 AM Par Pharma (PRX) Begins U.S. Shipments of Generic Symbyax (LLY)
Nov 14, 2012 02:33 PM Sizing Incyte (INCY) vs. Pfizer (PFE) in Treatment for Rheumatoid Arthritis
Nov 8, 2012 08:45 AM Boehringer, Lilly (LLY) Completes Enrollment in CAROLINA
Oct 30, 2012 07:46 AM Lilly (LLY) Cialis Approved as BPH Treatment in Europe
Oct 22, 2012 09:08 AM Eli Lilly (LLY) Reports Phase III AWARD Met All Primary Endpoints
Oct 19, 2012 10:57 AM Lilly's (LLY) Amyvid Receives Positive CHMP Opinion in the EU

Back to LLY Stock Lookup